Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health economic analysis.

Pareek M, Eborall HC, Wobi F, Ellis KS, Kontopantelis E, Zhang F, Baggaley R, Hollingsworth TD, Baines D, Patel H, Haldar P, Patel M, Stephenson I, Browne I, Gill P, Kapur R, Farooqi A, Abubakar I, Griffiths C.

BMJ Open. 2019 Mar 7;9(3):e029188. doi: 10.1136/bmjopen-2019-029188.

2.

Building a European database to gather multi-country evidence on active and latent TB screening for migrants.

Öhd JN, Lönnroth K, Abubakar I, Aldridge RW, Erkens C, Jonsson J, Marchese V, Matteelli A, Menezes D, Zenner D, Hergens MP.

Int J Infect Dis. 2019 Mar;80S:S45-S49. doi: 10.1016/j.ijid.2019.02.041. Epub 2019 Feb 28.

3.

Towards optimal treatment for latent Mycobacterium tuberculosis infection.

Abubakar I, Chakaya J, Maeurer M, Zumla A.

Lancet Respir Med. 2019 Mar;7(3):195-197. doi: 10.1016/S2213-2600(19)30036-0. No abstract available.

PMID:
30823969
4.

BCG vaccination following latent TB treatment: Possible implications for different settings.

Goscé L, Bitencourt J, Gupta RK, Arruda S, Rodrigues LC, Abubakar I.

Int J Infect Dis. 2019 Mar;80S:S17-S19. doi: 10.1016/j.ijid.2019.02.026. Epub 2019 Feb 25.

5.

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series.

Petersen E, Rao M, Ippolito G, Gualano G, Chakaya J, Ntoumi F, Moore D, Allen R, Gaskell K, Öhd JN, Hergens MP, Krishnamoorthy S, Ugarte-Gil C, Kirwan DE, Honeyborne I, McHugh TD, Köser CU, Kranzer K, Tiberi S, Migliori GB, Mao Q, Yang Y, Oliveira SP, Cardoso RF, Detjen A, Marais B, de Gijsel D, von Reyn CF, Goscé L, Abubakar I, Maeurer M, Zumla A.

Int J Infect Dis. 2019 Mar;80S:S1-S5. doi: 10.1016/j.ijid.2019.02.024. Epub 2019 Feb 23. No abstract available.

6.

Million Migrants study of healthcare and mortality outcomes in non-EU migrants and refugees to England: Analysis protocol for a linked population-based cohort study of 1.5 million migrants.

Burns R, Pathak N, Campos-Matos I, Zenner D, Vittal Katikireddi S, Muzyamba MC, Miranda JJ, Gilbert R, Rutter H, Jones L, Williamson E, Hayward AC, Smeeth L, Abubakar I, Hemingway H, Aldridge RW.

Wellcome Open Res. 2019 Jan 17;4:4. doi: 10.12688/wellcomeopenres.15007.1. eCollection 2019.

7.

Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial.

Story A, Aldridge RW, Smith CM, Garber E, Hall J, Ferenando G, Possas L, Hemming S, Wurie F, Luchenski S, Abubakar I, McHugh TD, White PJ, Watson JM, Lipman M, Garfein R, Hayward AC.

Lancet. 2019 Feb 21. pii: S0140-6736(18)32993-3. doi: 10.1016/S0140-6736(18)32993-3. [Epub ahead of print]

8.

Public health outcome of Tuberculosis Cluster Investigations, England 2010-2013.

Hamblion EL, Burkitt A, Lalor MK, Anderson LF, Thomas HL, Abubakar I, Morton S, Maguire H, Anderson SR; Public Health England TB Strain Typing Board.

J Infect. 2019 Jan 15. pii: S0163-4453(19)30004-0. doi: 10.1016/j.jinf.2018.12.004. [Epub ahead of print]

PMID:
30653984
9.

Reducing loss to follow-up during treatment for drug-resistant tuberculosis.

Abubakar I, Lipman M.

Eur Respir J. 2019 Jan 10;53(1). pii: 1802268. doi: 10.1183/13993003.02268-2018. Print 2019 Jan. No abstract available.

PMID:
30630854
10.

Mycobacterium tuberculosis transmission in an ethnically-diverse high incidence region in England, 2007-11.

Vynnycky E, Keen AR, Evans JT, Khanom S, Hawkey PM, White RG, Abubakar I.

BMC Infect Dis. 2019 Jan 7;19(1):26. doi: 10.1186/s12879-018-3585-8.

11.

Development of a data collection and management system in West Africa: challenges and sustainability.

Shaffer JG, Doumbia SO, Ndiaye D, Diarra A, Gomis JF, Nwakanma D, Abubakar I, Ahmad A, Affara M, Lukowski M, Valim C, Welty JC, Mather FJ, Keating J, Krogstad DJ.

Infect Dis Poverty. 2018 Nov 16;7(1):125. doi: 10.1186/s40249-018-0494-4.

12.

Children and adolescents on the move: what does the Global Compact for Migration mean for their health?

Devakumar D, Russell N, Murphy L, Wickramage K, Sawyer SM, Abubakar I.

Lancet Child Adolesc Health. 2019 Feb;3(2):64-66. doi: 10.1016/S2352-4642(18)30376-6. Epub 2018 Dec 6. No abstract available.

PMID:
30528682
13.

The UCL-Lancet Commission on Migration and Health: the health of a world on the move.

Abubakar I, Aldridge RW, Devakumar D, Orcutt M, Burns R, Barreto ML, Dhavan P, Fouad FM, Groce N, Guo Y, Hargreaves S, Knipper M, Miranda JJ, Madise N, Kumar B, Mosca D, McGovern T, Rubenstein L, Sammonds P, Sawyer SM, Sheikh K, Tollman S, Spiegel P, Zimmerman C; UCL–Lancet Commission on Migration and Health.

Lancet. 2018 Dec 15;392(10164):2606-2654. doi: 10.1016/S0140-6736(18)32114-7. Epub 2018 Dec 5. Review. No abstract available.

PMID:
30528486
14.

Global patterns of mortality in international migrants: a systematic review and meta-analysis.

Aldridge RW, Nellums LB, Bartlett S, Barr AL, Patel P, Burns R, Hargreaves S, Miranda JJ, Tollman S, Friedland JS, Abubakar I.

Lancet. 2018 Dec 15;392(10164):2553-2566. doi: 10.1016/S0140-6736(18)32781-8. Epub 2018 Dec 5.

15.

Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Steel N, Ford JA, Newton JN, Davis ACJ, Vos T, Naghavi M, Glenn S, Hughes A, Dalton AM, Stockton D, Humphreys C, Dallat M, Schmidt J, Flowers J, Fox S, Abubakar I, Aldridge RW, Baker A, Brayne C, Brugha T, Capewell S, Car J, Cooper C, Ezzati M, Fitzpatrick J, Greaves F, Hay R, Hay S, Kee F, Larson HJ, Lyons RA, Majeed A, McKee M, Rawaf S, Rutter H, Saxena S, Sheikh A, Smeeth L, Viner RM, Vollset SE, Williams HC, Wolfe C, Woolf A, Murray CJL.

Lancet. 2018 Nov 3;392(10158):1647-1661. doi: 10.1016/S0140-6736(18)32207-4. Epub 2018 Oct 24.

16.

Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants.

Zumla A, Abubakar I.

BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0.

17.

Universal health coverage for refugees and migrants in the twenty-first century.

Abubakar I, Zumla A.

BMC Med. 2018 Nov 26;16(1):216. doi: 10.1186/s12916-018-1208-2.

18.

Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.

Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review.

19.

Discordance in latent tuberculosis (TB) test results in patients with end-stage renal disease.

Southern J, Sridhar S, Tsou CY, Hopkins S, Collier S, Nikolayevskyy V, Lozewicz S, Lalvani A, Abubakar I, Lipman M.

Public Health. 2019 Jan;166:34-39. doi: 10.1016/j.puhe.2018.09.023. Epub 2018 Nov 12.

PMID:
30439554
20.

Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.

Abubakar I, Lalvani A, Southern J, Sitch A, Jackson C, Onyimadu O, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Kon OM, Hayward A, Lord J, Drobniewski F.

Health Technol Assess. 2018 Oct;22(56):1-96. doi: 10.3310/hta22560.

21.

Reconstruction giant cell tumor of the right proximal humerus Campanacci 3 with pedicle and rod system: A case report.

Prabowo Y, Abubakar I.

Int J Surg Case Rep. 2018;52:67-74. doi: 10.1016/j.ijscr.2018.08.042. Epub 2018 Aug 29.

22.

Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes.

Collin SM, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, Zenner D.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801449. doi: 10.1183/13993003.01449-2018. Print 2018 Dec.

PMID:
30309977
23.

Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.

Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Lynn W, Burgess H, Mann B, Imran A, Sridhar S, Tsou CY, Nikolayevskyy V, Rees-Roberts M, Whitworth H, Kon OM, Haldar P, Kunst H, Anderson S, Hayward A, Watson JM, Milburn H, Lalvani A; PREDICT Study Team.

Lancet Infect Dis. 2018 Oct;18(10):1077-1087. doi: 10.1016/S1473-3099(18)30355-4. Epub 2018 Aug 30.

24.

Postmenopausal osteoporosis and breast cancer: The biochemical links and beneficial effects of functional foods.

Muhammad A, Mada SB, Malami I, Forcados GE, Erukainure OL, Sani H, Abubakar IB.

Biomed Pharmacother. 2018 Nov;107:571-582. doi: 10.1016/j.biopha.2018.08.018. Epub 2018 Aug 14. Review.

PMID:
30114641
25.

Implications of converging conflicts, emergencies, and mass gatherings for global health security.

Elachola H, Doumbia S, Kattan RF, Abubakar I, Memish ZA.

Lancet Glob Health. 2018 Aug;6(8):e834-e835. doi: 10.1016/S2214-109X(18)30256-0. No abstract available.

26.

Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidence.

Winter JR, Adamu AL, Gupta RK, Stagg HR, Delpech V, Abubakar I.

Int J Tuberc Lung Dis. 2018 Jul 1;22(7):713-722. doi: 10.5588/ijtld.17.0672.

PMID:
29914596
27.

Trends in, and factors associated with, HIV infection amongst tuberculosis patients in the era of anti-retroviral therapy: a retrospective study in England, Wales and Northern Ireland.

Winter JR, Stagg HR, Smith CJ, Lalor MK, Davidson JA, Brown AE, Brown J, Zenner D, Lipman M, Pozniak A, Abubakar I, Delpech V.

BMC Med. 2018 Jun 7;16(1):85. doi: 10.1186/s12916-018-1070-2.

28.

Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.

Doyle RM, Burgess C, Williams R, Gorton R, Booth H, Brown J, Bryant JM, Chan J, Creer D, Holdstock J, Kunst H, Lozewicz S, Platt G, Romero EY, Speight G, Tiberi S, Abubakar I, Lipman M, McHugh TD, Breuer J.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00666-18. doi: 10.1128/JCM.00666-18. Print 2018 Aug.

29.

A review on the ethnomedicinal uses, phytochemistry and pharmacology of Alpinia officinarum Hance.

Abubakar IB, Malami I, Yahaya Y, Sule SM.

J Ethnopharmacol. 2018 Oct 5;224:45-62. doi: 10.1016/j.jep.2018.05.027. Epub 2018 May 25. Review.

PMID:
29803568
30.

Exploring the determinants of open defecation in Nigeria using demographic and health survey data.

Abubakar IR.

Sci Total Environ. 2018 Oct 1;637-638:1455-1465. doi: 10.1016/j.scitotenv.2018.05.104. Epub 2018 May 22.

PMID:
29801238
31.

Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort.

Jackson C, Southern J, Lalvani A, Drobniewski F, Griffiths CJ, Lipman M, Bothamley GH, Deeks JJ, Imran A, Kon OM, Mpofu S, Nikolayevskyy V, Rees-Roberts M, Sitch A, Sridhar S, Tsou CY, Whitworth H, Abubakar I.

Thorax. 2019 Jan;74(1):91-94. doi: 10.1136/thoraxjnl-2017-211124. Epub 2018 May 15.

32.

The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak.

Lalor MK, Casali N, Walker TM, Anderson LF, Davidson JA, Ratna N, Mullarkey C, Gent M, Foster K, Brown T, Magee J, Barrett A, Crook DW, Drobniewski F, Thomas HL, Abubakar I.

Eur Respir J. 2018 Jun 21;51(6). pii: 1702313. doi: 10.1183/13993003.02313-2017. Print 2018 Jun.

PMID:
29748309
33.

Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium.

Abubakar I, Matteelli A, de Vries G, Zenner D, Cirillo DM, Lönnroth K, Popescu G, Barcellini L, Story A, Migliori GB.

Eur Respir J. 2018 May 10;51(5). pii: 1702604. doi: 10.1183/13993003.02604-2017. Print 2018 May. No abstract available.

PMID:
29748241
34.

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update.

Migliori GB, Sotgiu G, Rosales-Klintz S, Centis R, D'Ambrosio L, Abubakar I, Bothamley G, Caminero JA, Cirillo DM, Dara M, de Vries G, Aliberti S, Dinh-Xuan AT, Duarte R, Midulla F, Solovic I, Subotic DR, Amicosante M, Correia AM, Cirule A, Gualano G, Kunst H, Palmieri F, Riekstina V, Tiberi S, Verduin R, van der Werf MJ.

Eur Respir J. 2018 May 17;51(5). pii: 1702678. doi: 10.1183/13993003.02678-2017. Print 2018 May.

PMID:
29678945
35.

Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening.

Melendez J, Hogeweg L, Sánchez CI, Philipsen RHHM, Aldridge RW, Hayward AC, Abubakar I, van Ginneken B, Story A.

Int J Tuberc Lung Dis. 2018 May 1;22(5):567-571. doi: 10.5588/ijtld.17.0492.

36.

Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.

Gupta RK, Lipman M, Story A, Hayward A, de Vries G, van Hest R, Erkens C, Rangaka MX, Abubakar I.

Int J Tuberc Lung Dis. 2018 May 1;22(5):479-487. doi: 10.5588/ijtld.17.0767.

PMID:
29663951
37.

Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions.

Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA.

Lancet Infect Dis. 2018 Aug;18(8):e228-e238. doi: 10.1016/S1473-3099(18)30134-8. Epub 2018 Apr 10. Review. Erratum in: Lancet Infect Dis. 2018 Nov;18(11):1177.

38.

Humanitarian disaster for Rohingya refugees: impending natural hazards and worsening public health crises.

Ahmed B, Orcutt M, Sammonds P, Burns R, Issa R, Abubakar I, Devakumar D.

Lancet Glob Health. 2018 May;6(5):e487-e488. doi: 10.1016/S2214-109X(18)30125-6. No abstract available.

39.

Synergistic Apoptotic Effects of Tocotrienol Isomers and Acalypha wilkesiana on A549 and U87MG Cancer Cells.

Abubakar IB, Lim SW, Loh HS.

Trop Life Sci Res. 2018 Mar;29(1):229-238. doi: 10.21315/tlsr2018.29.1.15. Epub 2018 Mar 2.

40.

Hepatitis C virus treatment as prevention in people who inject drugs.

White PJ, Abubakar I.

Lancet Infect Dis. 2018 Apr;18(4):379. doi: 10.1016/S1473-3099(18)30130-0. Epub 2018 Mar 21. No abstract available.

41.

Update in Tuberculosis and Nontuberculous Mycobacteria 2017.

Abubakar I, Gupta RK, Rangaka MX, Lipman M.

Am J Respir Crit Care Med. 2018 May 15;197(10):1248-1253. doi: 10.1164/rccm.201801-0106UP. No abstract available.

PMID:
29537298
42.

UK's role in global health research innovation.

Mannell J, Abubakar I, Bastawrous A, Osrin D, Patel P, Piot P, Prince M, Smith J, Wilkinson RJ, Horton R.

Lancet. 2018 Feb 24;391(10122):721-723. doi: 10.1016/S0140-6736(18)30303-9. No abstract available.

PMID:
29486932
43.

Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey.

Adetifa IMO, Adamu AL, Karani A, Waithaka M, Odeyemi KA, Okoromah CAN, Bello MM, Abubakar IS, Inem V, Scott JAG.

Sci Rep. 2018 Feb 22;8(1):3509. doi: 10.1038/s41598-018-21837-5.

44.

Assessment of data quality and reporting systems for underserved populations: the case of integrated community case management programs in Nigeria.

Nyangara FM, Hai T, Zalisk K, Ozor L, Ufere J, Isiguzo C, Abubakar IN.

Health Policy Plan. 2018 May 1;33(4):465-473. doi: 10.1093/heapol/czy003.

PMID:
29447403
45.

Comparing different technologies for active TB case-finding among the homeless: a transmission-dynamic modelling study.

Mugwagwa T, Stagg HR, Abubakar I, White PJ.

Sci Rep. 2018 Jan 23;8(1):1433. doi: 10.1038/s41598-018-19757-5.

46.

The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis.

Adamu AL, Aliyu MH, Galadanci NA, Musa BM, Lawan UM, Bashir U, Abubakar I.

Int J Equity Health. 2018 Jan 8;17(1):4. doi: 10.1186/s12939-017-0714-8.

47.

Eliminating tuberculosis in low-burden countries.

Jackson C, Cohen T, Rangaka MX, Abubakar I.

Int J Tuberc Lung Dis. 2018 Jan 1;22(1):3. doi: 10.5588/ijtld.17.0707. No abstract available.

PMID:
29297418
48.

Assessing uncertainty in the burden of hepatitis C virus: Comparison of estimated disease burden and treatment costs in the UK.

Gubay F, Staunton R, Metzig C, Abubakar I, White PJ.

J Viral Hepat. 2018 May;25(5):514-523. doi: 10.1111/jvh.12847. Epub 2018 Mar 1.

49.

Using peer advocates to improve access to services among hard-to-reach populations with hepatitis C: a qualitative study of client and provider relationships.

MacLellan J, Surey J, Abubakar I, Stagg HR, Mannell J.

Harm Reduct J. 2017 Nov 28;14(1):76. doi: 10.1186/s12954-017-0202-x.

50.

Post-migration follow-up of migrants at risk of tuberculosis.

White PJ, Abubakar I, Aldridge RW, Hayward AC.

Lancet Infect Dis. 2017 Nov;17(11):1124. doi: 10.1016/S1473-3099(17)30567-4. No abstract available.

Supplemental Content

Loading ...
Support Center